Depreciation of Tyra Biosciences, Inc. from 30 Sep 2020 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tyra Biosciences, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Sep 2020 to 31 Mar 2025.
  • Tyra Biosciences, Inc. Depreciation for the quarter ending 31 Mar 2025 was $100,000, unchanged year-over-year.
  • Tyra Biosciences, Inc. Depreciation for the twelve months ending 31 Mar 2025 was $500,000, a 25% increase year-over-year.
  • Tyra Biosciences, Inc. annual Depreciation for 2024 was $500,000, a 25% increase from 2023.
  • Tyra Biosciences, Inc. annual Depreciation for 2023 was $400,000, a 33% increase from 2022.
  • Tyra Biosciences, Inc. annual Depreciation for 2022 was $300,000, a 114% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Tyra Biosciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $500,000 $100,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $500,000 $200,000 +$100,000 +100% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $400,000 $100,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $400,000 $100,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $400,000 $100,000 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $400,000 $100,000 +$64,000 +178% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $336,000 $100,000 $0 0% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $336,000 $100,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $336,000 $100,000 +$36,000 +56% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $300,000 $36,000 +$88,896,000 01 Oct 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $88,596,000 $100,000 -$40,900,000 -100% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $47,696,000 $100,000 -$25,900,000 -100% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $21,796,000 $64,000 -$21,936,000 -100% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $140,000 $88,860,000 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $41,000,000 +$25,000,000 +156% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $26,000,000 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $22,000,000 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q3 2020 $16,000,000 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3

Tyra Biosciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $500,000 +$100,000 +25% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $400,000 +$100,000 +33% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $300,000 +$160,000 +114% 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
2021 $140,000 +$93,000 +198% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
2020 $47,000 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.